Reshaping in-vitro diagnostics
Building on 30 years of experience in transfusion diagnostics, we deliver game changing diagnostic solutions, empowering our customers to realize their full potential and improve their business.
Who we are
Quotient is a commercial-stage diagnostics company committed to delivering solutions that reshape the way diagnostics is practiced. The Company’s operations are based in Eysins, Switzerland; Edinburgh, Scotland and Newtown, Pennsylvania.
Originally established in Scotland in the 1940s, Quotient’s research and manufacturing subsidiary manufactured blood typing reagents as part of the Scottish National Blood Transfusion Service (SNBTS). In addition to supplying its products throughout the Scottish National Health System, the company grew and expanded its offerings as an Original Equipment Manufacturer (OEM) supplier to the world’s leading transfusion diagnostics companies. In 2007, it was privatized and became part of what is now Quotient.
Building on our strong heritage in transfusion diagnostics, we introduced our proprietary multiplexing microarray technology MosaiQ™ which offers the world’s first fully automated, consolidated testing platform, allowing for multiple tests across different modalities. MosaiQ™ is a game-changing solution designed to increase efficiencies, improve clinical practice, deliver significant workflow improvements and operational cost savings to laboratories around the world.
|2007||Quotient founded and acquired Alba Bioscience|
|2014||Quotient Suisse SA formed & Quotient IPO on Nasdaq|
|2018||72 reagents products CE marked, and 63 FDA licensed/cleared MosaiQ factory ISO certified and instrument CE marked|
|2019||Obtained CE mark for first microarray|